Back
Artiva Biotherapeutics, Inc. Stock Predictions
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Buy
65
ARTV
Artiva Biotherapeutics, Inc.
Last Price:
$4.81
Seasonality Move:
-67.7%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assetsArtiva Biotherapeutics, Inc. Stock Forecast
-
Is Artiva Biotherapeutics, Inc. Stock Undervalued?The current Artiva Biotherapeutics, Inc. [ARTV] share price is $4.78. The Score for ARTV is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ARTV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Artiva Biotherapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Artiva Biotherapeutics, Inc. Stock Rating
Data Unavailable
Artiva Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
artivabio.com
52-Week Data
52-Week High:
7.36
52-Week Low:
1.47
Prediction Charts
Market Cap:
116.5M
Price in USD:
4.78
Volume:
174.8K
Beta:
3.10
Technical Analysis
SMA50:
4.02
SMA100:
3.68
SMA200:
2.98
52-Wk Change:
-23.52%
Stock Predictions
-
Is Artiva Biotherapeutics, Inc. stock public?Yes, Artiva Biotherapeutics, Inc. is a publicly traded company.
-
What is the Artiva Biotherapeutics, Inc. stock quote today?The Artiva Biotherapeutics, Inc. stock price is 4.78 USD today.
-
How to buy Artiva Biotherapeutics, Inc. stock online?You can buy Artiva Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-5 | 4.25 | 4.17 | 4.31 | 4.12 |
| Jan-6 | 4.13 | 4.41 | 4.50 | 4.13 |
| Jan-7 | 4.38 | 4.60 | 4.68 | 4.38 |
| Jan-8 | 4.64 | 4.58 | 4.68 | 4.44 |
| Jan-9 | 4.60 | 4.86 | 4.90 | 4.50 |
| Jan-12 | 4.86 | 4.88 | 5.16 | 4.78 |
| Jan-13 | 4.97 | 4.60 | 4.97 | 4.53 |
| Jan-14 | 4.55 | 4.78 | 4.85 | 4.52 |
| Jan-15 | 4.81 | 4.46 | 4.81 | 4.40 |
| Jan-16 | 4.40 | 4.42 | 4.48 | 4.31 |
| Jan-20 | 4.32 | 4.62 | 4.69 | 4.20 |
| Jan-21 | 4.66 | 4.75 | 5.10 | 4.60 |
| Jan-22 | 4.83 | 4.95 | 4.97 | 4.75 |
| Jan-23 | 4.98 | 4.78 | 4.98 | 4.75 |
Artiva Biotherapeutics, Inc. Earnings
Data Unavailable
Artiva Biotherapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and a decrease next year of $0.12 per share.
* Artiva Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.